Intratio
量化研究
跳转到主要内容
市场摘要
正在加载市场情报...
  • 登录
    我的账户
    登出
AI 90天预测
检测到看涨信号
██.█% 免费注册以查看

Rigel Pharmaceuticals Inc（RIGL）AI预测

我们的AI检测到Rigel Pharmaceuticals Inc的重要信号。创建免费账户以查看精确的目标价。

✓ 免费账户 • ✓ 30天免费试用

$RIGL 看涨信号 完整预测可用
免费注册

Rigel Pharmaceuticals Inc (RIGL) 2025年股票预测

Rigel Pharmaceuticals Inc (RIGL) AI股价预测与投资分析

Rigel Pharmaceuticals Inc 股价图表和技术分析

正在加载图表...

Rigel Pharmaceuticals Inc (RIGL) - 全面股票分析与投资研究

深入了解Rigel Pharmaceuticals Inc的业务概况、财务表现、AI预测和竞争定位，以做出明智的投资决策。

分析更新于 四月 3, 2026, 9:39 a.m. (UTC)

Rigel Pharmaceuticals Inc投资摘要

在评估Rigel Pharmaceuticals Inc（RIGL）是否代表一个引人注目的投资机会时，投资者必须考虑多种因素，包括公司的财务状况、市场地位、增长前景，以及我们的AI驱动预测模型对其近期价格走势的预测。

公司概况

Rigel Pharmaceuticals Inc (RIGL) 位于Life Sciences行业，具体属于Pharmaceutical Preparations业务. 该公司雇佣约280名员工. 该公司市值为504百万美元，属于小盘股，可能提供更高的增长潜力，但也伴随更高的波动性。

财务表现分析

我们的全面财务分析涵盖Rigel Pharmaceuticals Inc的营收、盈利指标、资产负债表实力和现金流生成…

AI价格预测

获取Rigel Pharmaceuticals Inc的AI驱动7天、30天和90天价格预测，包括置信度评分和详细分析…

投资考量因素

专家分析Rigel Pharmaceuticals Inc是否适合您的投资目标、风险承受能力和投资期限…

继续阅读完整分析

获取Rigel Pharmaceuticals Inc的完整投资分析

免费注册
企业身份

Rigel Pharmaceuticals Inc (股票代码: RIGL) 是在Life Sciences板块运营的知名公司，专注于Pharmaceutical Preparations行业. 该公司的股票在Nasdaq交易所公开交易.

领导层与员工

关于Rigel Pharmaceuticals Inc领导团队、员工规模和组织结构的详细信息…

市场分类

Rigel Pharmaceuticals Inc的市值分析和股票分类（超大盘、大盘、中盘、小盘）…

板块与行业分析

Rigel Pharmaceuticals Inc的深入板块动态和行业背景…

解锁完整公司概况

获取关于Rigel Pharmaceuticals Inc的完整详情

免费注册
营收与增长分析

Rigel Pharmaceuticals Inc的年营收为 $294 百万 , 代表一家处于成长阶段的新兴公司。

盈利能力指标

Rigel Pharmaceuticals Inc的净利率、毛利率和营业利率分析…

市场估值

Rigel Pharmaceuticals Inc的市盈率、市净率和估值倍数…

回报指标

Rigel Pharmaceuticals Inc的净资产收益率（ROE）、总资产收益率（ROA）和资本效率…

解锁财务分析

获取Rigel Pharmaceuticals Inc的完整财务指标

免费注册
AI分析可用

解锁Rigel Pharmaceuticals Inc的AI价格预测

加入10,000+投资者，使用我们准确率超过67%的AI预测

4,000+ 已分析股票
67%+ 准确率
每日 更新
开始30天免费试用 →

✓ 30天免费试用 • ✓ 随时取消

战略市场地位

Rigel Pharmaceuticals Inc在高度动态的 Pharmaceutical Preparations市场中战略竞争. 作为小盘公司，它代表具有巨大增长潜力的新兴市场参与者。小盘股在获取市场份额和扩大运营规模时通常提供更大的增长潜力，尽管这伴随着更高的风险和波动性。在这一阶段的成功可以为识别出成功业务模式的早期投资者带来可观回报。

行业竞争格局

Rigel Pharmaceuticals Inc在Life Sciences板块竞争，应对该行业特有的竞争动态和市场力量。 该公司的竞争地位取决于其通过产品质量、成本效率、客户关系或其他与其特定市场细分相关的战略优势进行差异化的能力。

运营效率

该公司目前的自由现金流为负，为-1百万美元 . 负的自由现金流可能反映大量的增长投资、营运资金需求或运营挑战。这在激进投资的高增长公司中很常见，但对于成熟企业需要关注。

利润率与定价能力分析

该公司保持99.0%毛利率 反映了卓越的定价能力和/或轻资产商业模式。这一水平的毛利率通常见于软件、制药或奢侈品公司，这些公司的增量生产成本相对于售价微乎其微。这样的利润率表明显著的竞争优势保护公司免受价格竞争。

营业利润率为-90.6% 展示了公司在计入所有运营费用（包括研发、销售和营销以及一般管理费用）后将收入转化为营业利润的效率。 相对于毛利率的营业利润率压缩表明运营费用较高，可能需要效率改进或反映了必要的增长投资。

资产利用效率

资产周转率为0.47倍，表明 资本密集型行业（如公用事业、房地产或重工业）常见的适度资产周转率。由于运营所需的大量基础设施，这些行业的较低周转率是预期之中的。

财务实力与杠杆

流动比率为2.35 展示了强劲的短期流动性，流动资产显著超过流动负债。这为履行短期义务和应对意外财务需求提供了充足的缓冲。

Rigel Pharmaceuticals Inc (RIGL) 基本面分析与内部交易数据 (季度财务报告)

全面的季度财务数据、盈利趋势、内部交易和机构持仓，用于 Rigel Pharmaceuticals Inc 股票分析.

深入了解Rigel Pharmaceuticals Inc的财务健康状况、估值指标和运营效率，以做出明智的投资决策。

了解估值指标

这些指标的含义: 估值指标有助于确定 Rigel Pharmaceuticals Inc 的股票相对于其收益、资产和市场地位是否定价合理。

如何解读: 较低的市盈率可能表明股票被低估，而较高的市盈率则表明市场对增长的预期。市净率将市值与账面价值进行比较。

对于 Rigel Pharmaceuticals Inc: 市盈率为 1.37，市场 认为该股票可能被低估.

市盈率 1.37x
市净率 1.29x
市值 $504M
每股收益 $5.50
每股账面价值 $21.38
每股收入 $16.07
每股自由现金流 $-0.28
理解盈利能力指标

这些指标的含义: 这些比率衡量 Rigel Pharmaceuticals Inc 将收入转化为利润并为股东创造回报的效率。

如何解读: 较高的ROE/ROA表示更好的管理效率。利润率百分比显示不同运营层面的盈利能力。

对于 Rigel Pharmaceuticals Inc: -199.4%的净资产收益率 表明有改进空间 股东价值创造.

股本回报率 -199.4%
资产回报率 -46.5%
投资资本回报率 -99.1%
毛利率 99.0%
营业利润率 -90.6%
净利率 -99.9%
税前利润率 -101.3%
理解财务健康指标

这些指标的含义: 这些比率评估Rigel Pharmaceuticals Inc履行短期债务和有效管理债务水平的能力。

如何解读: 流动比率>2通常表现良好，速动比率>1显示强劲的流动性。较低的资产负债率表明保守的债务管理。

对于 Rigel Pharmaceuticals Inc: 2.35 的流动比率 表明流动性强劲.

流动比率 2.35x
速动比率 2.07x
资产负债率 4.39x
财务杠杆 21.93x
利息保障倍数 -14.4x
营运资金 $48M
理解现金流指标

这些指标的含义: 现金流指标揭示了Rigel Pharmaceuticals Inc从运营中产生现金并为增长计划提供资金的能力。

如何解读: 正的经营现金流至关重要。自由现金流显示可用于股息、回购或投资的资金。

对于 Rigel Pharmaceuticals Inc: $-1M 的自由现金流 表明需要关注的现金挑战.

自由现金流 -$1M
资本支出 -$1M
自由现金流/销售额 -0.7%
资本支出/销售额 0.9%
理解运营效率指标

这些指标的含义: 这些比率衡量Rigel Pharmaceuticals Inc使用资产和管理营运资本的有效性。

如何解读: 较高的周转率表明资产利用效率高。较短的收款期显示有效的信用管理。

对于 Rigel Pharmaceuticals Inc: 0.47倍的资产周转率 表明有改进空间 资产利用.

资产周转率 0.47x
应收账款周转率 1.1x
存货周转率 0.1x
固定资产周转率 6.1x
应收账款周转天数 338 天
存货周转天数 2818 天
应付账款周转期 1995 天
现金转换周期 1161 天
理解财务报表数据

这些指标的含义: 来自Rigel Pharmaceuticals Inc损益表和资产负债表的关键数据，显示绝对财务表现。

如何解读: 收入显示业务规模，而利润率表明盈利能力。资产负债表项目揭示财务结构。

对于 Rigel Pharmaceuticals Inc: 年收入为$294M，Rigel Pharmaceuticals Inc 展示了稳固的业务规模.

损益表
总收入 $294M
营业收入 -$169M
净收入 -$85M
研发费用 $68M
销售及管理费用 $114M
销售成本 $17M
资产负债表要点 (% 占资产的比例)
流动资产总额 93%
现金及短期投资 72%
负债总额 95%
应收账款 10%
库存 5%
股息与股东信息
流通股份 18M
增长指标（同比）
每股收益增长 -110.6%

最新 Rigel Pharmaceuticals Inc 股票新闻与市场分析

影响Rigel Pharmaceuticals Inc (RIGL) 股价和投资前景的突发新闻、分析师报告和市场更新。

更多新闻可用

免费注册以阅读所有7篇新闻文章，并了解市场最新动态。

免费注册以阅读更多

Rigel Pharmaceuticals Inc 竞争对手与同行分析 - Life Sciences 行业

Rigel Pharmaceuticals Inc在Life Sciences行业中与同行和竞争对手的比较分析，包括AI驱动的预测和关键财务指标。

公司 股票代码 90天AI预测 市值（百万美元） 市盈率 市净率
Aardvark Therapeutics, Inc. AARD ██% $88M x 0.8x
Abbvie Inc. ABBV ██% $379.29B 89.8x 270.9x
Abcellera Biologics Inc. ABCL ██% $1.07B -5.3x 1.1x
Abeona Therapeutics Inc. ABEO ██% $266M 3.7x 1.7x
Abbott Laboratories ABT ██% $179.10B 27.5x 3.4x
Arbutus Biopharma Corp ABUS ██% $865M -8.3x 11.3x
Abvc Biopharma, Inc. ABVC ██% $26M -0.3x 2.4x
Abivax S.A. ABVX ██% $9.25B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.78B 9.7x 3.1x
Adicet Bio, Inc. ACET ██% $66M -0.4x 0.4x
Aclaris Therapeutics, Inc. ACRS ██% $485M -4.5x 4.7x
Acrivon Therapeutics, Inc. ACRV ██% $57M -2.8x 0.5x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $6M x 7.6x
Acurx Pharmaceuticals, Inc. ACXP ██% $11M -0.8x 2.0x
Adagene Inc. ADAG ██% $210M x 5.5x
Adc Therapeutics Sa ADCT ██% $478M -9.2x -1.3x
Adial Pharmaceuticals, Inc. ADIL ██% $3M -0.1x 0.5x
Aditxt, Inc. ADTX ██% $450K 0.0x 0.1x
Addex Therapeutics Ltd. ADXN ██% $7M x x
Aeon Biopharma, Inc. AEON ██% $25M 6.4x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.99B 3.7x 1.7x
Ainos, Inc. AIMD ██% $8M -0.4x 1.1x
Akebia Therapeutics, Inc. AKBA ██% $376M -5.4x 11.5x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $5M -2.0x 0.2x
Aldeyra Therapeutics, Inc. ALDX ██% $104M -5.1x 2.4x
Alkermes Plc. ALKS ██% $5.70B 23.6x 3.1x
Allarity Therapeutics, Inc. ALLR ██% $18M -0.2x 1.9x
Alumis Inc. ALMS ██% $2.94B x 9.7x
Alnylam Pharmaceuticals, Inc. ALNY ██% $43.65B 139.1x 55.3x
Altimmune, Inc. ALT ██% $405M -5.7x 1.8x
Alx Oncology Holdings Inc ALXO ██% $259M -0.4x 10.0x
Alzamend Neuro, Inc. ALZN ██% $4M -0.1x 1.7x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.56B -1.5x 5.1x
Amphastar Pharmaceuticals, Inc. AMPH ██% $921M 9.4x 1.2x
Amarin Corp Plc\Uk AMRN ██% $302M -4.5x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $3.95B 54.8x 189.3x
Anaptysbio, Inc ANAB ██% $1.57B -2.5x 42.2x
Anebulo Pharmaceuticals, Inc. ANEB ██% $40M -4.3x 5.1x
Ani Pharmaceuticals Inc ANIP ██% $1.71B 21.8x 3.2x
Anixa Biosciences Inc ANIX ██% $90M -15.0x 6.0x
Annexon, Inc. ANNX ██% $806M -4.1x 3.8x
Alto Neuroscience, Inc. ANRO ██% $688M x 4.6x
An2 Therapeutics, Inc. ANTX ██% $125M x 2.4x
Annovis Bio, Inc. ANVS ██% $56M -1.0x 3.3x
Apollomics Inc. APLM ██% $32M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.11B 228.4x 13.8x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $8M -1.2x 0.6x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $22M x 2.7x
Aptevo Therapeutics Inc. APVO ██% $6M -0.1x 0.4x
Aquestive Therapeutics, Inc. AQST ██% $501M -10.7x 48.9x
Arcturus Therapeutics Holdings Inc. ARCT ██% $223M -7.0x 1.0x
Ardelyx, Inc. ARDX ██% $1.48B -21.3x 8.9x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.96B -6.6x 15.7x
Artelo Biosciences, Inc. ARTL ██% $6M -0.7x 9.9x
Arvinas, Inc. ARVN ██% $685M -4.8x 1.6x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $8.70B 43.0x 15.3x
Aspire Biopharma Holdings, Inc. ASBP ██% $5M x x
Assembly Biosciences, Inc. ASMB ██% $461M -1.5x 2.2x
Ascendis Pharma A/S ASND ██% $14.18B x x
Assertio Holdings, Inc. ASRT ██% $127M -0.2x 1.4x
Atai Beckley N.V. ATAI ██% $1.34B -4.4x 8.4x
Alterity Therapeutics Ltd ATHE ██% $67M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $31M -4.1x 4.0x
Atossa Therapeutics, Inc. ATOS ██% $44M -6.2x 1.1x
Avenue Therapeutics, Inc. ATXI ██% $1M -9.5x 0.7x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.05B 7.1x 3.5x
Arrivent Biopharma, Inc. AVBP ██% $1.03B x 3.3x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $444M -1.5x 1.6x
Avalo Therapeutics, Inc. AVTX ██% $381M -0.1x 4.6x
Axim Biotechnologies, Inc. AXIM ██% $2M x 0.4x
Axsome Therapeutics, Inc. AXSM ██% $8.75B -19.9x 99.1x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $4M -0.2x 1.0x
Bridgebio Pharma, Inc. BBIO ██% $14.50B -11.6x -5.4x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $722M x 1.8x
Bicara Therapeutics Inc. BCAX ██% $1.33B x 3.3x
Briacell Therapeutics Corp. BCTX ██% $29M -1.7x 0.9x
Bicycle Therapeutics Plc BCYC ██% $340M -6.0x 0.6x
Bioadaptives, Inc. BDPT ██% $130K x 11.1x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $14M -2.9x 6.7x
Biofrontera Inc. BFRI ██% $11M -0.1x 1.1x
Bio Green Med Solution, Inc. BGMS ██% $5M x 0.7x
Bausch Health Companies Inc. BHC ██% $2.07B 13.2x 3.7x
Bioharvest Sciences Inc. BHST ██% $98M x 3.8x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $787M x 2.9x
Bio Essence Corp BIOE ██% $6M 6.4x x
Biovie Inc. BIVI ██% $10M -0.6x 0.5x
Bioxytran, Inc BIXT ██% $5M x 5.9x
Biolinerx Ltd. BLRX ██% $10M x x
Belite Bio, Inc BLTE ██% $6.88B x 8.9x
Biomea Fusion, Inc. BMEA ██% $108M -1.6x 3.7x
Biomarin Pharmaceutical Inc BMRN ██% $11.01B 31.6x 1.8x
Bristol Myers Squibb Co BMY ██% $125.56B 17.8x 6.8x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $376M -0.6x 2.0x
Boundless Bio, Inc. BOLD ██% $25M -15.1x 0.3x
Bolt Biotherapeutics, Inc. BOLT ██% $9M -0.3x 0.3x
Bio-Path Holdings, Inc. BPTH ██% $550K 0.0x 3.4x
Bioquest Corp BQST ██% $14M x 2.8x
Barinthus Biotherapeutics Plc. BRNS ██% $22M -0.6x 0.3x
Bespoke Extracts, Inc. BSPK ██% $2M x 150.7x
Bioxcel Therapeutics, Inc. BTAI ██% $26M -0.1x 4.6x
Beyondspring Inc. BYSI ██% $69M 63.8x 1.3x
Calcimedica, Inc. CALC ██% $9M 0.4x 1.3x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.2x
Capricor Therapeutics, Inc. CAPR ██% $1.73B x 5.7x
Carisma Therapeutics Inc. CARM ██% $1M 0.2x 0.0x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $508M -2.8x 2.5x
Gyre Therapeutics, Inc. CBIO ██% $591M 59.8x 5.6x
Cdt Equity Inc. CDT ██% $19M -0.7x 4.4x
Cingulate Inc. CING ██% $70M -0.6x 27.9x
Cell Source, Inc. CLCS ██% $35M x 2917.3x
Clene Inc. CLNN ██% $52M -7.3x 12.3x
Cellectar Biosciences, Inc. CLRB ██% $11M x 1.2x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $1M x x
Climb Bio, Inc. CLYM ██% $474M -1.4x 3.0x
Chemomab Therapeutics Ltd. CMMB ██% $11M 10.9x 0.9x
Clearmind Medicine Inc. CMND ██% $3M x x
Compass Pathways Plc CMPS ██% $725M 0.0x 19.0x
Cnbx Pharmaceuticals Inc. CNBX ██% $90K x 0.1x
Cns Pharmaceuticals, Inc. CNSP ██% $1M 0.0x 0.3x
Centessa Pharmaceuticals Plc CNTA ██% $5.95B -11.0x 11.3x
Connect Biopharma Holdings Ltd CNTB ██% $154M x 3.7x
Canton Strategic Holdings, Inc. CNTN ██% $167M x 0.4x
Context Therapeutics Inc. CNTX ██% $243M -1.5x 4.0x
Cocrystal Pharma, Inc. COCP ██% $14M -1.0x 2.2x
Cogent Biosciences, Inc. COGT ██% $5.67B -3.7x 8.9x
Collegium Pharmaceutical, Inc COLL ██% $1.05B 16.8x 3.5x
Corcept Therapeutics Inc CORT ██% $4.50B 45.2x 7.0x
Coya Therapeutics, Inc. COYA ██% $96M -6.8x 2.2x
China Pharma Holdings, Inc. CPHI ██% $3M -0.2x 0.4x
Cumberland Pharmaceuticals Inc CPIX ██% $46M -4.5x 1.9x
Cannapharmarx, Inc. CPMD ██% $3M x 1.9x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.04B 14.2x 3.2x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $176M -2.0x 1.2x
Cormedix Inc. CRMD ██% $554M 3.4x 1.4x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.50B -15.9x 3.5x
Cervomed Inc. CRVO ██% $37M -0.7x 2.0x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.21B -13.7x 19.8x
Cytomx Therapeutics, Inc. CTMX ██% $986M 29.5x 10.0x
Contineum Therapeutics, Inc. CTNM ██% $502M x 1.9x
Citius Oncology, Inc. CTOR ██% $55M 3.9x 0.9x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Citius Pharmaceuticals, Inc. CTXR ██% $19M -5.3x 0.2x
Cue Biopharma, Inc. CUE ██% $20M -1.2x 0.7x
Curanex Pharmaceuticals Inc CURX ██% $14M x 1.3x
Cadrenal Therapeutics, Inc. CVKD ██% $11M -11.1x 4.2x
Cv Sciences, Inc. CVSI ██% $6M x 4.4x
Cyclerion Therapeutics, Inc. CYCN ██% $24M -5.2x 2.7x
Cytodyn Inc. CYDY ██% $335M 86.7x 123.5x
Cypherpunk Technologies Inc. CYPH ██% $63M 13.1x 0.4x
Cryoport, Inc. CYRX ██% $424M 5.4x 0.8x
Cytokinetics Inc CYTK ██% $8.20B -9.4x 71.5x
Dare Bioscience, Inc. DARE ██% $28M 2.9x 9.7x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.21B -8.9x 5.0x
Decoy Therapeutics Inc. DCOY ██% $3M x 0.5x
Journey Medical Corp DERM ██% $154M 24.1x 4.8x
Diamedica Therapeutics Inc. DMAC ██% $344M -4.2x 6.1x
Damora Therapeutics, Inc. DMRA ██% $1.52B x 6.3x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.48B -3.2x 9.1x
Dermata Therapeutics, Inc. DRMA ██% $4M -0.2x 0.6x
Bright Minds Biosciences Inc. DRUG ██% $702M x x
Design Therapeutics, Inc. DSGN ██% $678M -7.6x 3.2x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $71M -2.9x 1.0x
Dyne Therapeutics, Inc. DYN ██% $3.01B -7.8x 3.1x
Emergent Biosolutions Inc. EBS ██% $437M 8.3x 0.8x
Edesa Biotech, Inc. EDSA ██% $46M -1.3x 3.3x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $8M -8.2x 1.0x
Elanco Animal Health Inc ELAN ██% $11.49B 341.6x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $226M x 2.8x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $408M 14.9x 5.1x
Elicio Therapeutics, Inc. ELTX ██% $190M -1.9x 116.0x
Enliven Therapeutics, Inc. ELVN ██% $2.25B -13.3x 4.9x
Emmaus Life Sciences, Inc. EMMA ██% $910K x 0.3x
Enlivex Ltd. ENLV ██% $230M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $2M x 0.6x
Enanta Pharmaceuticals Inc ENTA ██% $381M -1.3x 3.0x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $3M -0.1x 0.7x
Evolus, Inc. EOLS ██% $280M -13.1x 56.9x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $451M x 5.5x
Equillium, Inc. EQ ██% $125M -3.2x 4.4x
Erasca, Inc. ERAS ██% $4.72B -3.1x 14.5x
Ernexa Therapeutics Inc. ERNA ██% $6M x 2.6x
Esperion Therapeutics, Inc. ESPR ██% $670M -4.2x 78.5x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $686M -66.2x 26.2x
Earth Science Tech, Inc. ETST ██% $26M 6.5x 4.6x
Evofem Biosciences, Inc. EVFM ██% $1M 2.7x 0.1x
Evommune, Inc. EVMN ██% $844M x 4.1x
Edgewise Therapeutics, Inc. EWTX ██% $3.52B -19.7x 6.7x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $77M 11.4x 1.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $5M x 0.8x
Forte Biosciences, Inc. FBRX ██% $315M -11.5x 5.2x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $278M -3.3x 2235.9x
Filana Therapeutics, Inc. FLNA ██% $83M x 1.1x
Amicus Therapeutics, Inc. FOLD ██% $4.49B -8.5x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $517M -36.1x 1.5x
Galectin Therapeutics Inc GALT ██% $174M -2.4x 203.7x
Gain Therapeutics, Inc. GANX ██% $82M -1.4x 4.4x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $230K x x
Cytomed Therapeutics Ltd GDTC ██% $12M x x
Geron Corp GERN ██% $1.06B -11.9x 4.7x
Gh Research Plc GHRS ██% $913M x x
Galmed Pharmaceuticals Ltd. GLMD ██% $3M x 0.2x
Galapagos Nv GLPG ██% $1.96B x x
Greenwich Lifesciences, Inc. GLSI ██% $317M -17.2x 145.0x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $115M -2.8x 9.9x
Genprex, Inc. GNPX ██% $4M -3.2x 0.4x
Gossamer Bio, Inc. GOSS ██% $85M -3.2x 2.5x
Geovax Labs, Inc. GOVX ██% $3M x 0.6x
Structure Therapeutics Inc. GPCR ██% $3.74B -44.0x 2.5x
Grace Therapeutics, Inc. GRCE ██% $76M -3.9x 1.2x
Gridai Technologies Corp. GRDX ██% $8M x 0.4x
Gri Bio, Inc. GRI ██% $3M -0.1x 0.6x
Galera Therapeutics, Inc. GRTX ██% $3M 0.0x 0.8x
Gsk Plc GSK ██% $112.78B x x
Gt Biopharma, Inc. GTBP ██% $13M x 2.2x
Gyre Therapeutics, Inc. GYRE ██% $660M 66.8x 6.2x
Hutchmed (China) Ltd HCM ██% $2.75B 3.0x 2.2x
Hcw Biologics Inc. HCWB ██% $2M x 0.6x
Cybin Inc. HELP ██% $249M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $640K -0.1x 0.2x
Vyome Holdings, Inc HIND ██% $15M x 6.2x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $13M -1.0x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $9M -0.5x 1.4x
Werewolf Therapeutics, Inc. HOWL ██% $47M -1.3x 1.9x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.61B 10.2x 1.9x
Heron Therapeutics, Inc. /De/ HRTX ██% $151M -6.4x 10.6x
Hst Global, Inc. HSTC ██% $44M x 35.4x
Tuhura Biosciences, Inc./Nv HURA ██% $96M x 4.6x
Mindwalk Holdings Corp. HYFT ██% $53M x x
Hyperion Defi, Inc. HYPD ██% $27M x 0.7x
Ibio, Inc. IBIO ██% $67M -0.4x 1.2x
Impact Biomedical Inc. IBO ██% $66M x 5.3x
Ideaya Biosciences, Inc. IDYA ██% $2.85B -12.2x 2.8x
Inflarx N.V. IFRX ██% $65M x x
Igc Pharma, Inc. IGC ██% $25M -4.6x 3.4x
Immutep Ltd IMMP ██% $55M x x
Immix Biopharma, Inc. IMMX ██% $456M x 4.9x
Immunome Inc. IMNM ██% $2.54B -2.4x 4.0x
Imunon, Inc. IMNN ██% $10M -0.5x 1.5x
Immuron Ltd IMRN ██% $8M x x
Immuneering Corp IMRX ██% $348M -0.8x 1.6x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $147M -0.8x 13.8x
Integrated Biopharma Inc INBP ██% $9M 14.8x 0.4x
Indaptus Therapeutics, Inc. INDP ██% $4M -0.6x 1.2x
Indivior Pharmaceuticals, Inc. INDV ██% $3.83B 18.2x x
Inmed Pharmaceuticals Inc. INM ██% $2M -51.8x 0.2x
Inovio Pharmaceuticals, Inc. INO ██% $120M -0.6x 5.0x
Insmed Inc INSM ██% $35.32B -14.0x 47.8x
Inhibitor Therapeutics, Inc. INTI ██% $19M x 6197.3x
Innoviva, Inc. INVA ██% $1.73B 6.4x 1.5x
Io Biotech, Inc. IOBT ██% $3M -0.7x 3.3x
Ionis Pharmaceuticals Inc IONS ██% $12.16B -14.6x 24.9x
Opus Genetics, Inc. IRD ██% $328M -2.0x 21.4x
Disc Medicine, Inc. IRON ██% $2.49B -18.4x 3.4x
Ironwood Pharmaceuticals Inc IRWD ██% $636M 26.5x 0.7x
International Stem Cell Corp ISCO ██% $1M x 0.4x
Iterum Therapeutics Plc ITRM ██% $2M -0.8x 1.1x
Inventiva S.A. IVA ██% $1.13B x x
Incannex Healthcare Inc. IXHL ██% $40M x 0.5x
Jaguar Health, Inc. JAGX ██% $5M -0.2x 0.8x
Janux Therapeutics, Inc. JANX ██% $876M -63.7x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $11.49B 14.3x 2.7x
Jade Biosciences, Inc. JBIO ██% $761M x 2.3x
Johnson & Johnson JNJ ██% $585.09B 21.8x 7.2x
Jupiter Neurosciences, Inc. JUNS ██% $13M x 233.0x
Kala Bio, Inc. KALA ██% $149M -0.5x 27.3x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.01B -2.6x 55.0x
Kairos Pharma, Ltd. KAPA ██% $12M x 1.9x
Kaya Holdings, Inc. KAYS ██% $22M x x
Kamada Ltd KMDA ██% $489M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.57B 60.5x 6.3x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $131M -0.6x 2.1x
Keros Therapeutics, Inc. KROS ██% $356M 4.1x 1.2x
Korro Bio, Inc. KRRO ██% $182M -7.9x 3.6x
Pasithea Therapeutics Corp. KTTA ██% $17M -73.5x 0.3x
Kura Oncology, Inc. KURA ██% $733M -4.5x 4.2x
Kyntra Bio, Inc. KYNB ██% $29M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M -3.2x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $711M x 2.4x
Legend Biotech Corp LEGN ██% $3.52B x x
Lexaria Bioscience Corp. LEXX ██% $25M -29.3x 5.1x
Lifecore Biomedical, Inc. \De\ LFCR ██% $144M x 106.3x
Lifevantage Corp LFVN ██% $54M 6.8x 1.6x
Ligand Pharmaceuticals Inc LGND ██% $3.95B 31.7x 3.9x
Longeveron Inc. LGVN ██% $31M -0.5x 5.5x
Lianbio LIANY ██% $15M x 0.1x
Lftd Partners Inc. LIFD ██% $4M 42.9x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $230K -3.3x 0.2x
Lite Strategy, Inc. LITS ██% $42M x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $26M -0.9x 2.7x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $839.50B 40.7x 31.6x
Lunai Bioworks Inc. LNAI ██% $9M 5.6x x
Lipocine Inc. LPCN ██% $68M -2.6x 4.7x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $3.25B -7.2x 72.7x
Larimar Therapeutics, Inc. LRMR ██% $486M -0.8x 6.2x
Lisata Therapeutics, Inc. LSTA ██% $44M -1.0x 3.0x
Lantern Pharma Inc. LTRN ██% $16M -2.4x 2.5x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $695M -1.2x 6.5x
Lyell Immunopharma, Inc. LYEL ██% $442M -1.1x 1.8x
Maia Biotechnology, Inc. MAIA ██% $82M -1.4x 34.4x
Mustang Bio, Inc. MBIO ██% $6M -0.1x 0.6x
Moleculin Biotech, Inc. MBRX ██% $12M -2.3x 0.8x
Mbx Biosciences, Inc. MBX ██% $1.45B x 3.9x
Seres Therapeutics, Inc. MCRB ██% $85M 14.9x 1.9x
Medicus Pharma Ltd. MDCX ██% $12M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $12.10B -5.7x 20.1x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $184M -2.1x 3.3x
Mira Pharmaceuticals, Inc. MIRA ██% $44M -1.6x 4.3x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.71B -20.0x 18.1x
Milestone Pharmaceuticals Inc. MIST ██% $145M -2.0x 3.5x
Moonlake Immunotherapeutics MLTX ██% $1.23B -50.8x 4.1x
Mineralys Therapeutics, Inc. MLYS ██% $2.15B -4.5x 3.3x
Mannkind Corp MNKD ██% $782M 133.4x 41.6x
Medicinova Inc MNOV ██% $70M -7.1x 1.7x
Monopar Therapeutics MNPR ██% $379M -3.0x 2.8x
Maplight Therapeutics, Inc. MPLT ██% $945M x 2.1x
Mereo Biopharma Group Plc MREO ██% $53M x 1.3x
Merck & Co., Inc. MRK ██% $302.34B 16.6x 5.8x
Marker Therapeutics, Inc. MRKR ██% $22M -0.6x 1.3x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.06B -5.6x 5.0x
Matinas Biopharma Holdings, Inc. MTNB ██% $4M -1.7x 0.7x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $6M -0.5x 1.2x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.73B x 5.5x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $428M 22.0x 2.7x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $40M 8.0x 34.1x
Newcelx Ltd. NCEL ██% $11M x 19.8x
Nucana Plc NCNA ██% $6M x x
Minerva Neurosciences, Inc. NERV ██% $228M -0.8x 42.6x
Neuphoria Therapeutics Inc. NEUP ██% $22M x 0.8x
Neurogene Inc. NGNE ██% $336M -7.3x 1.3x
Nika Pharmaceuticals, Inc NIKA ██% $398M x 192879.0x
Nektar Therapeutics NKTR ██% $2.17B -1.2x 24.2x
Nkarta, Inc. NKTX ██% $156M -1.3x 0.5x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $21M -2.1x 1.9x
Nurix Therapeutics, Inc. NRIX ██% $1.58B -7.4x 2.9x
Neurosense Therapeutics Ltd. NRSN ██% $25M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $70M -0.6x 9.0x
Neonc Technologies Holdings, Inc. NTHI ██% $140M x x
Nuvation Bio Inc. NUVB ██% $1.52B -1.2x 5.0x
Nuvalent, Inc. NUVL ██% $7.49B -30.9x 6.0x
Nuvectis Pharma, Inc. NVCT ██% $194M -3.9x 10.5x
Novartis Ag NVS ██% $293.68B x x
Northwest Biotherapeutics Inc NWBO ██% $304M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $37M -0.5x 1.1x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.80B -8.2x 2.8x
Oragenics Inc OGEN ██% $2M -0.1x 0.3x
Organigram Global Inc. OGI ██% $185M x x
Organon & Co. OGN ██% $1.60B 8.6x 2.1x
Onkure Therapeutics, Inc. OKUR ██% $58M -6.9x 1.0x
Olema Pharmaceuticals, Inc. OLMA ██% $1.22B -4.0x 2.6x
Omeros Corp OMER ██% $798M -4.2x 36.9x
Beone Medicines Ltd. ONC ██% $35.43B 123.5x 8.1x
Onconetix, Inc. ONCO ██% $1M -0.3x 0.1x
Oncolytics Biotech Inc ONCY ██% $100M x x
Opko Health, Inc. OPK ██% $849M -3.5x 0.7x
Organogenesis Holdings Inc. ORGO ██% $285M 7.7x 1.0x
Orgenesis Inc. ORGS ██% $6M 0.9x 0.3x
Oric Pharmaceuticals, Inc. ORIC ██% $837M -4.2x 2.2x
Oruka Therapeutics, Inc. ORKA ██% $2.46B x 5.2x
Oramed Pharmaceuticals Inc. ORMP ██% $133M 2.1x 0.7x
Os Therapies Inc OSTX ██% $50M x 13.2x
Oncotelic Therapeutics, Inc. OTLC ██% $18M x 1.9x
Ovid Therapeutics Inc. OVID ██% $326M -2.6x 2.5x
One World Products, Inc. OWPC ██% $750K x 0.8x
Phibro Animal Health Corp PAHC ██% $2.24B 26.3x 6.7x
Prestige Consumer Healthcare Inc. PBH ██% $2.76B 14.8x 1.5x
Psyence Biomedical Ltd. PBM ██% $5M x x
Puma Biotechnology, Inc. PBYI ██% $341M 11.0x 2.6x
Pacira Biosciences, Inc. PCRX ██% $926M 131.7x 1.3x
Processa Pharmaceuticals, Inc. PCSA ██% $7M -0.5x 1.2x
Procyon Corp PCYN ██% $2M x 1.0x
Pds Biotechnology Corp PDSB ██% $33M -1.7x 3.6x
Pepgen Inc. PEPG ██% $120M -1.6x 0.8x
Pfizer Inc PFE ██% $162.25B 20.9x 1.9x
Precigen, Inc. PGEN ██% $1.39B -1.4x 66.5x
Phathom Pharmaceuticals, Inc. PHAT ██% $796M -1.6x 45.1x
Phio Pharmaceuticals Corp. PHIO ██% $15M -0.8x 0.7x
Pharvaris N.V. PHVS ██% $1.91B x x
Protokinetix, Inc. PKTX ██% $2M x 7.2x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $81M -4.5x 0.5x
Polomar Health Services, Inc. PMHS ██% $4M x 0.6x
Promis Neurosciences Inc. PMN ██% $113M -2.1x 17.1x
Pmv Pharmaceuticals, Inc. PMVP ██% $71M -1.6x 0.7x
Purple Biotech Ltd. PPBT ██% $7M x x
Propanc Biopharma, Inc. PPCB ██% $2M x 0.2x
Praxis Precision Medicines, Inc. PRAX ██% $8.04B -4.0x 9.2x
Prf Technologies Ltd. PRFX ██% $2M x 0.2x
Perrigo Co Plc PRGO ██% $1.51B -27.6x 0.5x
Prelude Therapeutics Inc PRLD ██% $217M -0.5x 3.2x
Prophase Labs, Inc. PRPH ██% $380K -0.5x 0.1x
Proqr Therapeutics N.V. PRQR ██% $180M x x
Prothena Corp Public Ltd Co PRTA ██% $540M -12.4x 1.9x
Ptc Therapeutics, Inc. PTCT ██% $5.60B 8.2x 3857.9x
Protagonist Therapeutics, Inc PTGX ██% $6.49B 119.5x 10.6x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M -2.8x 1.2x
Palatin Technologies Inc PTN ██% $30M x 2.7x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K -0.1x 0.1x
Pulmatrix, Inc. PULM ██% $5M -1.8x 1.3x
Provectus Biopharmaceuticals, Inc. PVCT ██% $20M x 6.2x
Palvella Therapeutics, Inc. PVLA ██% $1.72B x 61.6x
Pyxis Oncology, Inc. PYXS ██% $92M -1.3x 1.7x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $11M x 0.8x
Quantum Biopharma Ltd. QNTM ██% $26M x x
Q32 Bio Inc. QTTB ██% $89M 3.0x 2.1x
Mainz Biomed N.V. QUCY ██% $6M x 9.3x
Uniqure N.V. QURE ██% $1.05B -2.8x 5.3x
Radiopharm Theranostics Ltd RADX ██% $34M x x
Rani Therapeutics Holdings, Inc. RANI ██% $80M -1.3x 2.4x
Rapport Therapeutics, Inc. RAPP ██% $1.51B x 3.1x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.07B -7.0x 218.2x
Rocket Pharmaceuticals, Inc. RCKT ██% $392M -4.8x 1.4x
Arcus Biosciences, Inc. RCUS ██% $2.74B -5.5x 4.3x
Dr Reddys Laboratories Ltd RDY ██% $11.25B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $81.30B 18.1x 2.6x
Revelation Biosciences, Inc. REVB ██% $5M -0.1x 0.5x
Rafael Holdings, Inc. RFL ██% $64M -0.9x 0.8x
Regen Biopharma Inc RGBP ██% $130K x 1.5x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $504M 1.4x 1.3x
Relmada Therapeutics, Inc. RLMD ██% $745M -0.1x 8.6x
Rallybio Corp RLYB ██% $44M -0.7x 0.8x
Retrieve Medical Holdings, Inc. RMHI ██% $24M x 337.7x
Rockwell Medical, Inc. RMTI ██% $37M -17.1x 1.0x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $166M -2.1x 218.6x
Transcode Therapeutics, Inc. RNAZ ██% $7M -0.2x 5.0x
Rein Therapeutics, Inc. RNTX ██% $34M x 2.0x
Renovorx, Inc. RNXT ██% $47M -3.4x 8.6x
Roivant Sciences Ltd. ROIV ██% $19.95B 1.8x 4.7x
Royalty Pharma Plc RPRX ██% $28.05B 36.4x 4.3x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x 6425307.7x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $10M -4.1x 1.2x
Rhythm Pharmaceuticals, Inc. RYTM ██% $5.92B -20.3x 42.6x
Rezolute, Inc. RZLT ██% $299M -3.9x 2.3x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $5M -0.6x 0.2x
Scienture Holdings, Inc. SCNX ██% $12M 2.9x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $730K 0.0x 0.0x
Scynexis Inc SCYX ██% $39M -2.4x 0.8x
Schrodinger, Inc. SDGR ██% $848M -7.8x 2.3x
Septerna, Inc. SEPN ██% $1.09B x 2.9x
Serina Therapeutics, Inc. SER ██% $26M 22.6x 14.8x
Sagimet Biosciences Inc. SGMT ██% $169M x 1.5x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $4M x 1.7x
Siga Technologies Inc SIGA ██% $370M 15.9x 1.9x
Silo Pharma, Inc. SILO ██% $5M x 0.8x
Sionna Therapeutics, Inc. SION ██% $1.81B x 5.9x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $22M -0.7x 1.1x
Sol-Gel Technologies Ltd. SLGL ██% $271M x 11.9x
Silence Therapeutics Plc SLN ██% $258M x 4.2x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $1.93B 92.6x 4.3x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $728M -1.0x 10.3x
Summit Therapeutics Inc. SMMT ██% $14.67B 104.1x 22.3x
Semnur Pharmaceuticals, Inc. SMNR ██% $1.84B x x
Syndax Pharmaceuticals Inc SNDX ██% $2.09B -4.1x 32.3x
Soligenix, Inc. SNGX ██% $12M -1.8x 2.2x
Sibannac, Inc. SNNC ██% $1M x 2.0x
Sensei Biotherapeutics, Inc. SNSE ██% $39M -0.4x 2.1x
Sanofi SNY ██% $116.24B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $97M -0.4x 2.3x
Scisparc Ltd. SPRC ██% $2M x x
Spero Therapeutics, Inc. SPRO ██% $138M 16.1x 2.3x
Ars Pharmaceuticals, Inc. SPRY ██% $805M -23.5x 7.1x
Sarepta Therapeutics, Inc. SRPT ██% $2.32B 162.5x 2.0x
Stoke Therapeutics, Inc. STOK ██% $1.88B 45.5x 5.4x
Shattuck Labs, Inc. STTK ██% $447M x 5.4x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.96B 46.0x 2.8x
Savara Inc SVRA ██% $1.14B -8.2x 5.6x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $5M -0.6x 1.3x
Synlogic, Inc. SYBX ██% $7M 3.6x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $3.82B -0.7x 5.4x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $59.30B x x
Theravance Biopharma, Inc. TBPH ██% $809M 7.6x 2.7x
Alaunos Therapeutics, Inc. TCRT ██% $7M -1.0x 3.2x
Telomir Pharmaceuticals, Inc. TELO ██% $44M x 7.4x
Tenax Therapeutics, Inc. TENX ██% $275M -14.9x 2.8x
Terns Pharmaceuticals, Inc. TERN ██% $5.93B -5.1x 5.9x
Teva Pharmaceutical Industries Ltd TEVA ██% $34.78B 24.7x 4.4x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $5.22B 11.7x 8.1x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $38M -2.3x 2.3x
Telix Pharmaceuticals Ltd TLX ██% $3.13B x x
Tango Therapeutics, Inc. TNGX ██% $2.94B -2.8x 8.5x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $178M 0.0x 0.7x
Theriva Biologics, Inc. TOVX ██% $11M -0.4x 0.7x
Tempest Therapeutics, Inc. TPST ██% $23M -0.5x 3.4x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $503M 6.9x 1.7x
Trevi Therapeutics, Inc. TRVI ██% $1.49B -6.1x 8.1x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $92M x 19.6x
Tvardi Therapeutics, Inc. TVRD ██% $28M x 1.3x
Travere Therapeutics, Inc. TVTX ██% $2.86B x 24.9x
Therapeuticsmd, Inc. TXMD ██% $23M 538.2x 0.9x
Tyra Biosciences, Inc. TYRA ██% $2.13B -9.5x 8.2x
Unicycive Therapeutics, Inc. UNCY ██% $179M -0.9x 5.9x
Upstream Bio, Inc. UPB ██% $503M x 1.5x
Urogen Pharma Ltd. URGN ██% $917M -2.5x 35.0x
United Therapeutics Corp UTHR ██% $24.75B 18.5x 3.5x
Vaccinex, Inc. VCNX ██% $2M -0.1x 0.4x
Vera Therapeutics, Inc. VERA ██% $2.59B -20.4x 4.3x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vg Life Sciences Inc. VGLS ██% $4M x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.99B -67.5x 6.3x
Vanda Pharmaceuticals Inc. VNDA ██% $402M -16.1x 1.2x
Verrica Pharmaceuticals Inc. VRCA ██% $92M -0.5x 3.7x
Viridian Therapeutics, Inc.\De VRDN ██% $1.92B -4.5x 2.7x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $113.02B 28.6x 6.1x
Verastem, Inc. VSTM ██% $497M -6.5x 8.7x
Vistagen Therapeutics, Inc. VTGN ██% $25M -0.1x 0.5x
Viatris Inc VTRS ██% $15.63B -29.5x 1.0x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $20M -0.4x 0.7x
Whitehawk Therapeutics, Inc. WHWK ██% $169M x 1.2x
Wave Life Sciences Ltd. WVE ██% $1.30B -22.2x 2.5x
Xenetic Biosciences, Inc. XBIO ██% $6M x 0.8x
Xbiotech Inc. XBIT ██% $72M -3.5x 0.5x
Exicure, Inc. XCUR ██% $26M -1.9x 6.6x
Xenon Pharmaceuticals Inc. XENE ██% $5.42B -15.4x 9.3x
Xeris Biopharma Holdings, Inc. XERS ██% $1.01B 1827.2x 74.0x
Xilio Therapeutics, Inc. XLO ██% $49M -0.5x 1.4x
Xencor Inc XNCR ██% $921M -8.4x 1.5x
Xoma Royalty Corp XOMA ██% $393M 12.4x 4.7x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.17B x 4.8x
Zai Lab Ltd ZLAB ██% $2.33B -95.2x 3.3x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $185M -1.4x 0.9x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $50.12B 18.8x 15.0x
Zevra Therapeutics, Inc. ZVRA ██% $532M 6.4x 3.4x
Zyversa Therapeutics, Inc. ZVSA ██% $1M x 0.3x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
显示所有预测 查看所有竞争对手的精确%预测
免费注册

常见问题 - Rigel Pharmaceuticals Inc 股票预测

Rigel Pharmaceuticals Inc的股票预测有多准确？

我们的AI模型对RIGL预测展示了17%的历史准确率，基于超过10年市场数据训练的先进机器学习算法。

哪些因素影响Rigel Pharmaceuticals Inc的股价预测？

我们的分析考虑了Rigel Pharmaceuticals Inc的财务指标、Life Sciences行业趋势、市场情绪、技术指标、盈利数据以及影响股票表现的宏观经济因素。

Rigel Pharmaceuticals Inc在2025年是一项好的投资吗？

根据我们的AI分析，Rigel Pharmaceuticals Inc显示 各种市场情况的潜力. 在做出投资决策之前，请考虑您的风险承受能力、投资时间表和投资组合多样化。

Rigel Pharmaceuticals Inc的预测多久更新一次？

Rigel Pharmaceuticals Inc的股票预测每天使用实时市场数据更新，确保您获得最新的AI驱动的预测和投资见解。

想要Rigel Pharmaceuticals Inc的更简洁视图吗？

在AI Stock Finder上查看简化分析 →

我的投资组合

投资仪表板

正在加载您的投资组合...